A Study to Compare the Efficacy and Safety of Obinutuzumab + GDC-0199 versus Obinutuzumab + Chlorambucil in Patients with Chronic Lymphocytic Leukemia

Update Il y a 4 ans
Reference: EUCTR2014-001810-24

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine efficacy by investigator-assessed PFS of a combined regimen of obinutuzumab and Venetoclax compared with GClb in previously untreated patients with CLL who have coexisting medical conditions.


Inclusion criteria

  • Chronic lymphocytic leukemia